Could a single injection rebuild knees? phase 3 trial underway
Disease control
Ongoing
This Phase 3 trial tests a single injection of TG-C, a cell-based treatment, in 535 people with moderate knee osteoarthritis. The goal is to see if it reduces pain and improves knee function compared to a placebo injection. Participants are followed for two years to check safety …
Phase: PHASE3 • Sponsor: Kolon TissueGene, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC